CEST reveals significant molecular changes in the brain regions for depression assessment, suggesting potential biomarkers.
Motivation: Revealing molecular alterations in the brain can provide a better assessment of depression and can benefit treatment planning. Goal(s): Our findings would serve as potential biomarkers for the assessment of depression. Approach: Here we applied CEST to study the regional brain changes in a depression model. Results: CEST, with multi-parametric readout, showed significant changes at the cortex and thalamus, which attributed to the alterations in molecular content and the exchange rate (P<0.05). Additionally, we observed that female mice tended to have higher CEST signals than male mice in the hippocampus and thalamus under depression (P<0.05). Impact: The molecular findings here can provide valuable information for the development of CEST in psychiatry. CEST is non-invasive and non-contrast-enhanced, which can be translated to the clinical level for better diagnosis and treatment planning for depression.
No takes yet. Share an insight, caveat, or question.
Lai et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: